Sanofi (SNYN) - Total Liabilities

Latest as of December 2025: MX$55.09 Billion MXN ≈ $3.17 Billion USD

Based on the latest financial reports, Sanofi (SNYN) has total liabilities worth MX$55.09 Billion MXN (≈ $3.17 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sanofi - Total Liabilities Trend (2013–2025)

This chart illustrates how Sanofi's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Sanofi Competitors by Total Liabilities

The table below lists competitors of Sanofi ranked by their total liabilities.

Company	Country	Total Liabilities
Newmont Corporation AU:NEM	Australia	AU$23.09 Billion
China Merchants Bank Co Ltd SHG:600036	China	CN¥11.36 Trillion
BP p.l.c MX:BPN	Mexico	MX$204.53 Billion
Progressive Corp NYSE:PGR	USA	$86.49 Billion
Banco Bilbao Vizcaya Argentaria SA MC:BBVA	Spain	€751.25 Billion
Enbridge Inc TO:ENB	Canada	CA$152.55 Billion
Capital One Financial Corporation NYSE:COF	USA	$555.39 Billion
China Shenhua Energy Co SHG:601088	China	CN¥212.43 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Sanofi's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.77	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.43	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sanofi's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sanofi (2013–2025)

The table below shows the annual total liabilities of Sanofi from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	MX$55.09 Billion ≈ $3.17 Billion	+0.28%
2024-12-31	MX$54.94 Billion ≈ $3.16 Billion	+5.43%
2023-12-31	MX$52.11 Billion ≈ $3.00 Billion	+2.03%
2022-12-31	MX$51.07 Billion ≈ $2.94 Billion	-0.27%
2021-12-31	MX$51.21 Billion ≈ $2.95 Billion	-0.33%
2020-12-31	MX$51.38 Billion ≈ $2.96 Billion	-4.19%
2019-12-31	MX$53.63 Billion ≈ $3.09 Billion	+2.40%
2018-12-31	MX$52.37 Billion ≈ $3.01 Billion	+25.99%
2017-12-31	MX$41.57 Billion ≈ $2.39 Billion	-11.46%
2016-12-31	MX$46.95 Billion ≈ $2.70 Billion	+6.43%
2015-12-31	MX$44.11 Billion ≈ $2.54 Billion	+7.26%
2014-12-31	MX$41.12 Billion ≈ $2.37 Billion	+5.39%
2013-12-31	MX$39.02 Billion ≈ $2.25 Billion	--

About Sanofi

MX:SNYN Mexico Drug Manufacturers - General

Market Cap

$117.45 Billion

MX$2.04 Trillion MXN

Market Cap Rank

#203 Global

#8 in Mexico

Share Price

MX$845.00

Change (1 day)

+4.32%

52-Week Range

MX$793.00 - MX$1035.00

All Time High

MX$1212.00